Replies to post #3487 on GTC Biotherapeutics (fka GTCB)

[waynebio]

Isn't Dr Cox the Chairman CEO and President of a company that has a poison pill in place with no majority owner....so he is the most in the driver's seat for allowing a buyout?

Also, isn't he very, very, very, very, very, very, very, very replaceable (please let me know what he can do that another good manager can't)?

[waynebio]

I am not talking about Dr Mead, I am talking about the powers that be (mostly Dr. Cox) that could allow a buy out. Yes Dr. Mead and others would be retained.

I like Dr. Cox's strategy, it has been spot on and steady for years at a time, and has the highest probability of suceess given available resources, but when the strategy yields the valuable fruit, it all becomes bigger than Dr. Cox the manager, but he remains the one most in the driver's seat for allowing a friendly merger as the CEO Chair and President. His interests must be considered when figuring the likely point (dollar value per share) when a friendly merger would be granted. $4 a share is likely not enough for Dr. Cox's interest's given he owns only 1mm shares, and he should not be interested in selling out prior to completing the US phase III and/or DIC phase II or III. It is just not lucrative enough for him or the shareholders.